EUVIMEDEUVIMED entdecken
Crossref

Neurokinin B Inhibition Preserves BBB Integrity in Ischemic Stroke via Suppression of Egr‐1‐Mediated Claudin‐5 Downregulation

Jijing Fu, Lihua Song, Fumin Ping, Ran Wang, Hui Li, Bo Yang, Suli Dong iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Jijing Fu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, Hebei Engineering University Affiliated Hospital, Handan, Hebei, China. Hauptthemen laut MEDLINE: Claudin-5, Blood-Brain Barrier, Ischemic Stroke, Early Growth Response Protein 1. Die Arbeit nennt 32 Literaturangaben. Gefördert von: This study was supported by the "Directive project for the 2019 medical research project plan in Hebei Province (20190128)"..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood‐Brain Barrier (BBB) dysfunction acts as a key mediator of ischemic brain injury, contributing to brain edema, inflammatory cell infiltration, and neuronal damage. The integrity of the BBB is largely maintained by tight junction proteins, such as Claudin‐5, and its disruption exacerbates neurological deficits. Neurokinin B (NKB), a neuropeptide that belongs to the tachykinin family, has been implicated in various physiological processes, including neuroinflammation and vascular function. However, the precise effects of NKB on BBB integrity during ischemic stroke have not been thoroughly investigated. Herein, we explore the role of NKB and its receptor, NKB receptor 3 (NK3R), in the context of ischemic stroke. Our results show a significant increase in both NKB and NK3R levels in the infarcted hemisphere of middle cerebral artery occlusion (MCAO)‐operated mice. When we experimentally reduced NKB levels, we observed a notable decrease in infarct volume, improved neurological function, and better BBB permeability. Additionally, we found that inhibiting NKB restored the expression of Claudin‐5, which in turn reduced endothelial permeability in both in vivo and in vitro experiments. We additionally recognized early growth response protein 1 (Egr‐1) as a critical downstream target of NKB, which plays a key role in compromising the endothelial barrier. Silencing Egr‐1 effectively reversed the increase in endothelial permeability and the decrease in Claudin‐5 caused by NKB, highlighting an important regulatory pathway. These findings emphasize the involvement of NKB in the disruption of the BBB during ischemic stroke, primarily through the upregulation of Egr‐1, which leads to reduced Claudin‐5 expression. Therefore, targeting NKB could be a promising therapeutic strategy for maintaining BBB integrity and reducing neuronal damage after ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Claudin-5Blood-Brain BarrierIschemic StrokeEarly Growth Response Protein 1Down-RegulationNeurokinin BAnimalsMiceMaleHumansMice, Inbred C57BLInfarction, Middle Cerebral Artery

Stichwörter der Autor:innen

Claudin‐5Egr‐1NKBblood‐brain barrierstroke

Substanzen

Claudin-5Early Growth Response Protein 1Cldn5 protein, mouseNeurokinin BEgr1 protein, mouse

Autor:innen und Institutionen

  • Department of Intensive Care Medicine, Hebei Engineering University Affiliated Hospital, Handan, Hebei, China.
  • Department of Cardiology, Hebei Engineering University Affiliated Hospital, Handan, Hebei, China.
  • Department of Surgical, Hebei Engineering University Affiliated Hospital, Handan, Hebei, China.
  • Department of Emergency, Hebei Engineering University Affiliated Hospital, Handan, Hebei, China.
  • Department of Rehabilitation Medicine, Hebei Engineering University Affiliated Hospital, Handan, Hebei, China.

ORCID-Profile: Suli Dong

Förderung

  • This study was supported by the "Directive project for the 2019 medical research project plan in Hebei Province (20190128)".

Zitieren

APA

Fu, J., Song, L., Ping, F., Wang, R., Li, H., Yang, B., & Dong, S. (2025). Neurokinin B Inhibition Preserves BBB Integrity in Ischemic Stroke via Suppression of Egr‐1‐Mediated Claudin‐5 Downregulation. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70483

Vancouver

Fu J, Song L, Ping F, Wang R, Li H, Yang B, et al. Neurokinin B Inhibition Preserves BBB Integrity in Ischemic Stroke via Suppression of Egr‐1‐Mediated Claudin‐5 Downregulation. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70483

BibTeX
@article{Fu2025,
  author = {Fu, Jijing and Song, Lihua and Ping, Fumin and Wang, Ran and Li, Hui and Yang, Bo and Dong, Suli},
  title = {Neurokinin B Inhibition Preserves BBB Integrity in Ischemic Stroke via Suppression of Egr‐1‐Mediated Claudin‐5 Downregulation},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70483}
}
Kostenlos starten →